{
"NDC": {
"NDCCode": "51991-885-01",
"PackageDescription": "100 TABLET in 1 BOTTLE (51991-885-01) ",
"NDC11Code": "51991-0885-01",
"ProductNDC": "51991-885",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Acetazolamide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Acetazolamide",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20200901",
"EndMarketingDate": "20220831",
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA207503",
"LabelerName": "Breckenridge Pharmaceutical, Inc.",
"SubstanceName": "ACETAZOLAMIDE",
"StrengthNumber": "250",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2022-09-01",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": null,
"StartMarketingDatePackage": "20200901",
"EndMarketingDatePackage": "20220831",
"SamplePackage": "N"
}
}